Magdalena Mazurkiewicz
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage.
Journal: Biochemical pharmacology
Published: July 14, 2018
A drug screening assay on cancer cells chronically adapted to acidosis.
Journal: Cancer cell international
Published: June 04, 2018
Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition.
Journal: Oncotarget
Published: December 02, 2016
Corrigendum: The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells.
Journal: Scientific reports
Published: July 30, 2016
The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells.
Journal: Scientific reports
Published: November 24, 2015
Inhibition of proteasome deubiquitinase activity: a strategy to overcome resistance to conventional proteasome inhibitors?
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: March 22, 2015
Crosstalk between Hippo and TGFβ: Subcellular Localization of YAP/TAZ/Smad Complexes.
Journal: Journal of molecular biology
Published: December 17, 2014
The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death.
Journal: Molecular pharmacology
Published: April 10, 2014
Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress.
Journal: Antioxidants & redox signaling
Published: September 10, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026